Infliximab: the evidence for its place in therapy in ulcerative colitis

INTRODUCTION: Refractory ulcerative colitis has a high, unmet medical need for avoiding steroid dependency and avoiding colectomy. Controlled trials with biologic agents have recently been reported. AIMS: We aimed to review the current evidence supporting the use of the monoclonal antitumor necrosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Assche, Gert, Vermeire, Séverine, Rutgeerts, Paul
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Place in Therapy Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012439/
https://www.ncbi.nlm.nih.gov/pubmed/21221182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012439/
https://www.ncbi.nlm.nih.gov/pubmed/21221182

Ejemplares similares